← Back to Search

ECRP + BCBT for Suicide Risk Reduction

Phase 2
Waitlist Available
Led By Michael S Esterman, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up worst point (administered at baseline and the 2, 4, 8, and 12-month post-discharge assessments)
Awards & highlights

Study Summary

This trial is exploring if longer psychotherapy & neuroimaging scans can help reduce suicide risk in Veterans. It's using 136 participants to see if the treatments are effective & how brain markers may predict suicide attempts.

Who is the study for?
This trial is for English-speaking Veterans who've been hospitalized due to recent suicidal thoughts or attempts. They must be able to attend 12 therapy sessions and 3 MRI scans post-discharge. It's not suitable for those with significant cognitive impairments or current psychotic/manic features.Check my eligibility
What is being tested?
The study compares two psychotherapies: Brief Cognitive Behavioral Therapy (BCBT) and Enhanced Crisis Response Planning (ECRP), assessing their effectiveness in improving coping skills, reducing negative thinking, and lowering suicide risk among Veterans.See study design
What are the potential side effects?
While the trial involves psychological interventions rather than medications, participants may experience emotional discomfort discussing sensitive topics during therapy sessions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~worst point (administered at baseline and the 2, 4, 8, and 12-month post-discharge assessments)
This trial's timeline: 3 weeks for screening, Varies for treatment, and worst point (administered at baseline and the 2, 4, 8, and 12-month post-discharge assessments) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Self-Injurious Thoughts and Behaviors Interview-Revised (SITBI-R)
Secondary outcome measures
Scale for Suicide Ideation (SSI)

Trial Design

2Treatment groups
Active Control
Group I: Brief Cognitive Behavioral Therapy for Suicide Prevention (BCBT)Active Control1 Intervention
This weekly, 12-session intervention involves completion of an enhanced crisis response plan, as well as emotion regulation skills training, learning strategies to identify and challenge thinking patterns that contribute to suicide risk, and increased engagement in personally meaningful activities.
Group II: Enhanced Crisis Response PlanningActive Control1 Intervention
Using supportive listening, a therapist conducts a brief interview to gather information about lifetime suicide attempt history and recent SI. The therapist then works with the client to identify a) warning signs for being in crisis, b) self-management/distraction strategies, c) reasons for living, d) sources of social support the client could contact in the event of a crisis, and e) crisis resources (e.g., veterans crisis line, contact information for current providers and local emergency resources). Steps for each of these, as well as specific contacts for social support and professional services are written on an index card provided to the patient and the patient is encouraged to keep the card in an accessible place (e.g., wallet) so it can be utilized in the event of a crisis.

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,609 Previous Clinical Trials
3,306,467 Total Patients Enrolled
38 Trials studying Suicide
5,482 Patients Enrolled for Suicide
Michael S Esterman, PhDPrincipal InvestigatorVA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
Daniel J. Lee, PhDPrincipal InvestigatorVA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA

Media Library

Brief Cognitive Behavioral Therapy for Suicide Prevention (BCBT) Clinical Trial Eligibility Overview. Trial Name: NCT05931289 — Phase 2
Suicide Research Study Groups: Brief Cognitive Behavioral Therapy for Suicide Prevention (BCBT), Enhanced Crisis Response Planning
Suicide Clinical Trial 2023: Brief Cognitive Behavioral Therapy for Suicide Prevention (BCBT) Highlights & Side Effects. Trial Name: NCT05931289 — Phase 2
Brief Cognitive Behavioral Therapy for Suicide Prevention (BCBT) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05931289 — Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available slots to participate in the clinical trial?

"The clinicaltrials.gov database shows that this particular medical trial, originally posted on the 1st of November 2023 and last updated sometime in late June of 2023, is no longer actively recruiting patients. Nevertheless, there are still 179 other similar trials currently seeking participants."

Answered by AI

Has Enhanced Crisis Response Planning received clearance from the FDA?

"As this is a Phase 2 trial, with only limited data supporting safety but no information regarding efficacy, Enhanced Crisis Response Planning received an estimated risk rating of 2."

Answered by AI
~91 spots leftby Dec 2027